{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:51:49Z","timestamp":1782291109841,"version":"3.54.5"},"reference-count":25,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum toxin type A (BoNT-A) is an established treatment for cervical dystonia (CD), but objective neurophysiological markers across the injection cycle and between preparations are not well defined. We assessed afferent conduction (captured by CSP parameters), efferent conduction (captured by F-wave parameters) and clinical severity (TWSTRS) in 28 patients with caput-type cervical dystonia during waning (&gt;14 weeks post-injection) and peak (4\u20136 weeks) phases, comparing onabotulinumtoxinA (ONA) and abobotulinumtoxinA (ABO). F-wave measures changed only modestly: F\u2013M latency increased with ONA, while F-wave persistence decreased with ABO. In contrast, CSP measures consistently increased at peak in both groups (CSP end latency and CSP duration; both p \u2264 0.001). Overall, BoNT-A treatment phase is better reflected by CSP-derived inhibitory measures than by F-wave indices. TWSTRS improved at peak for both toxins, with no difference between ONA and ABO in clinical change (\u0394TWSTRS p = 0.5514).<\/jats:p>","DOI":"10.3390\/toxins18070277","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:57:24Z","timestamp":1782287844000},"page":"277","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two Toxins, One Disorder: Neurophysiological and Clinical Effects in Caput-Type of Cervical Dystonia at Waning and Peak Response Phases of BoNT-A Therapy"],"prefix":"10.3390","volume":"18","author":[{"given":"Artur","family":"Dru\u017cd\u017c","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Prince Mieszko I Poznan Medical University of Applied Sciences, 60-320 Pozna\u0144, Poland"},{"name":"Department of Neurology, Municipal Hospital, 61-285 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Dudzic","sequence":"additional","affiliation":[{"name":"Department of Neurology, Municipal Hospital, 61-285 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Bednarski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Central University Hospital, 92-213 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sowi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Computer Science and Statistics, Pozna\u0144 University of Medical Sciences, 61-701 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8588-3241","authenticated-orcid":false,"given":"Natalie","family":"G\u00f3rna","sequence":"additional","affiliation":[{"name":"Department of Orthodontics and Temporomandibular Disorders, Pozna\u0144 University of Medical Sciences, 60-812 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-9819","authenticated-orcid":false,"given":"Agnieszka","family":"Przysta\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Pozna\u0144 University of Medical Sciences, 60-781 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref_1","unstructured":"Dru\u017cd\u017c, A., Dec-\u0106wiek, M., Jost, W., Nowak, P., Przysta\u0144ska, A., Schinwelski, M., S\u0142awek, J., and Tatu, L. (2022). Ultrasonography in Cervical Dystonia: Colour Atlas, Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mdc3.12172","article-title":"Selection of muscles for botulinum toxin injections in cervical dystonia","volume":"2","author":"Jost","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_3","first-page":"43","article-title":"Are botulinum toxin type A preparations really the same medication? A comparison of three botulinum toxin A formulations in labelled neurological indications","volume":"44","author":"Car","year":"2010","journal-title":"Neurol. I Neurochir. Pol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/mdc3.13696","article-title":"Conversion to AbobotulinumtoxinA increases waning time and efficacy for cervical dystonia","volume":"10","author":"Samotus","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neucli.2004.09.005","article-title":"F-waves: Neurophysiology and clinical value","volume":"34","author":"Mesrati","year":"2004","journal-title":"Neurophysiol. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1100\/tsw.2007.49","article-title":"F-waves\u2014Physiology and clinical uses","volume":"7","author":"Fisher","year":"2007","journal-title":"Sci. World J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11062-015-9528-8","article-title":"F-wave in the upper extremities of patients with primary torsion dystonia","volume":"47","author":"Semerdjieva","year":"2015","journal-title":"Neurophysiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.clinph.2006.03.002","article-title":"F wave study in amyotrophic lateral sclerosis: Assessment of balance between upper and lower motor neuron involvement","volume":"117","author":"Argyriou","year":"2006","journal-title":"Clin. Neurophysiol."},{"key":"ref_9","first-page":"199","article-title":"Motor nerve conduction velocities calculated by F tacheodispersion in patients with anterior horn diseases","volume":"36","author":"Chroni","year":"1996","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/(SICI)1097-4598(199904)22:4<467::AID-MUS7>3.0.CO;2-Y","article-title":"The cutaneous silent period is mediated by spinal inhibitory reflex","volume":"22","author":"Logigian","year":"1999","journal-title":"Muscle Nerve"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/NSN.NSN_38_20","article-title":"Cutaneous silent period","volume":"37","year":"2020","journal-title":"Neurol. Sci. Neurophysiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/WNL.46.2.503","article-title":"Cutaneous electromyographic silent period findings in brachial dystonia","volume":"46","author":"Pullman","year":"1996","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dru\u017cd\u017c, A., Le\u015bniewska-Furs, E., Dudzic, M., Sowi\u0144ska, A., Jurga, S., and Jost, W.H. (2025). Neurophysiological assessment of F-wave, M-wave, and cutaneous silent period in patients with caput-pattern cervical dystonia at waning and peak response phases of botulinum toxin therapy. Toxins, 18.","DOI":"10.3390\/toxins18010021"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1388-2457(01)00478-3","article-title":"Remote F-wave changes after local botulinum toxin application","volume":"112","author":"Wohlfarth","year":"2001","journal-title":"Clin. Neurophysiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.clinph.2019.01.003","article-title":"Cutaneous Silent Periods\u2014Part 2: Update on Pathophysiology and Clinical Utility","volume":"130","author":"Kofler","year":"2019","journal-title":"Clin. Neurophysiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s12640-021-00378-2","article-title":"Botulinum injections for idiopathic cervical dystonia: A longitudinal study","volume":"39","author":"Yahalom","year":"2021","journal-title":"Neurotox. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/jnnp-2012-303608","article-title":"Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia","volume":"84","author":"Dressler","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/mds.29387","article-title":"Isolated cervical dystonia: Diagnosis and classification","volume":"38","author":"Albanese","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S1388-2457(03)00028-2","article-title":"Reference values of F wave parameters in healthy subjects","volume":"114","author":"Puksa","year":"2003","journal-title":"Clin. Neurophysiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clinph.2019.01.002","article-title":"Cutaneous silent periods\u2014Part 1: Update on physiological mechanisms","volume":"130","author":"Kofler","year":"2019","journal-title":"Clin. Neurophysiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5455\/medarh.2014.68.98-101","article-title":"Cutaneous silent period in the evaluation of small nerve fibres","volume":"68","author":"Denislic","year":"2014","journal-title":"Med. Arch."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.54029\/2022pvi","article-title":"Sympathetic skin response, cutaneous silent period and nociceptive flexion reflex in Fabry disease","volume":"27","author":"Seyahi","year":"2022","journal-title":"Neurol. Asia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1055\/s-0042-1755229","article-title":"Recording cutaneous silent period parameters in hereditary and acquired neuropathies","volume":"80","author":"Neves","year":"2022","journal-title":"Arq. Neuro-Psiquiatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/mds.25579","article-title":"Dystonia rating scales: Critique and recommendations","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/mdc3.14222","article-title":"Interdisciplinary consensus in evaluating the severity subscale of the original and revised Toronto Western Spasmodic Torticollis Rating Scale through video-based assessment: An inter-rater reliability study","volume":"11","author":"Kassaye","year":"2024","journal-title":"Mov. Disord. Clin. Pract."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/277\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:41:47Z","timestamp":1782290507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["toxins18070277"],"URL":"https:\/\/doi.org\/10.3390\/toxins18070277","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}